TechForce Robotics, Inc., a subsidiary of Nightfood Holdings, Inc. (OTCQB: NGTF), has completed the initial deployment of its LIM-E autonomous laboratory support robot at Oncotelic Therapeutics. This marks the company's first operational entry into pharmaceutical and laboratory automation, fulfilling Phase 1 objectives under a joint development agreement to evaluate robotics and AI-enhanced systems for future GMP-regulated pharmaceutical manufacturing and laboratory workflows.
Laboratory and pharmaceutical operations increasingly face the same challenge that has accelerated automation across industries: how to improve efficiency while freeing highly trained personnel to focus on higher-value work. Researchers, technicians, and production staff often spend significant time on routine logistics tasks that do not directly advance scientific work or manufacturing output. As labor costs rise and productivity demands grow, organizations are exploring automation solutions capable of supporting operational scalability without disrupting tightly regulated workflows.
TechForce Robotics is positioning itself to address that opportunity by extending its Robotics-as-a-Service (RaaS) platform from hospitality into laboratory settings. The LIM-E robot is designed to handle routine logistics, such as transporting materials and samples, thereby allowing skilled personnel to concentrate on core scientific and production activities.
A new strategic alliance with JJ Enterprise adds advanced manufacturing, machine vision, and precision engineering expertise that could support the expansion of high-precision AI-driven applications. This partnership is expected to enhance TechForce's capabilities in developing and deploying automation solutions that meet the rigorous demands of pharmaceutical production.
The implications of this announcement are significant for the pharmaceutical and biotechnology sectors. By integrating autonomous robots into laboratory workflows, companies can potentially increase throughput, reduce errors, and improve compliance with regulatory standards. The RaaS model also lowers the barrier to entry for adopting automation, as it allows organizations to pay for robotic services as an operational expense rather than a large capital investment.
Investors can find the latest news and updates relating to NGTF in the company’s newsroom at https://ibn.fm/NGTF. TechMediaWire, a specialized communications platform, provides coverage of pioneering companies like TechForce Robotics. For more information, visit https://www.TechMediaWire.com.
